In conclusion, there is evidence that nuclear ARRB1 interacts with EZH2 to promote acetylation of histone H4 and expression of BCR/ABL promoting progression of CML. Here, EZH2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.